scholarly journals Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis

2020 ◽  
Vol 26 ◽  
pp. 102234
Author(s):  
Pavel Filip ◽  
Alena Svatkova ◽  
Adam F Carpenter ◽  
Lynn E Eberly ◽  
Igor Nestrasil ◽  
...  
2015 ◽  
Vol 22 (5) ◽  
pp. 608-619 ◽  
Author(s):  
Marita Daams ◽  
Martijn D Steenwijk ◽  
Menno M Schoonheim ◽  
Mike P Wattjes ◽  
Lisanne J Balk ◽  
...  

Background: Cognitive deficits are common in multiple sclerosis. Most previous studies investigating the imaging substrate of cognitive deficits in multiple sclerosis included patients with relatively short disease durations and were limited to one modality/brain region. Objective: To identify the strongest neuroimaging predictors for cognitive dysfunction in a large cohort of patients with long-standing multiple sclerosis. Methods: Extensive neuropsychological testing and multimodal 3.0T MRI was performed in 202 patients with multiple sclerosis and 52 controls. Cognitive scores were compared between groups using Z-scores. Whole-brain, white matter, grey matter, deep grey matter and lesion volumes; cortical thickness, (juxta)cortical and cerebellar lesions; and extent and severity of diffuse white matter damage were measured. Stepwise linear regression was used to identify the strongest predictors for cognitive dysfunction. Results: All cognitive domains were affected in patients. Patients showed extensive atrophy, focal pathology and damage in up to 75% of the investigated white matter. Associations between imaging markers and average cognition were two times stronger in cognitively impaired patients than in cognitively preserved patients. The final model for average cognition consisted of deep grey matter DGMV volume and fractional anisotropy severity (adjusted R²=0.490; p<0.001). Conclusion: From all imaging markers, deep grey matter atrophy and diffuse white matter damage emerged as the strongest predictors for cognitive dysfunction in long-standing multiple sclerosis.


2016 ◽  
Vol 87 (11) ◽  
pp. 1212-1217 ◽  
Author(s):  
Matteo Pardini ◽  
Carole H Sudre ◽  
Ferran Prados ◽  
Özgür Yaldizli ◽  
Varun Sethi ◽  
...  

The Lancet ◽  
2013 ◽  
Vol 381 (9884) ◽  
pp. 2222 ◽  
Author(s):  
Merel J A Luitse ◽  
Charlotte J J van Asch ◽  
Catharina J M Klijn

2000 ◽  
Vol 6 (6) ◽  
pp. 386-390 ◽  
Author(s):  
M. Zorzon ◽  
M. Ukmar ◽  
L. Monti Bragadin ◽  
F. Zanier ◽  
R.M. Antonello ◽  
...  

2021 ◽  
Vol 48 ◽  
pp. 102690
Author(s):  
Maija Saraste ◽  
Svetlana Bezukladova ◽  
Marcus Sucksdorff ◽  
Virva Saunavaara ◽  
Eero Rissanen ◽  
...  

2003 ◽  
Vol 16 (3) ◽  
pp. 365-372 ◽  
Author(s):  
F. Caranci ◽  
A. D'Amico ◽  
F. Briganti ◽  
R. Migliorati ◽  
C. De Fusco ◽  
...  

Erithrophagocytic lymphohistiocytosis is a rare disease characterized by exaggerated histiocytic proliferation and activation12 and multisystem involvement including visceral organs, lymph nodes, bone marrow and central nervous system4. Magnetic Resonance (MR) examination was performed in 10 patients with previously diagnosed Erithrophagocytic lymphohistiocytosis. This study was aimed at assessing MR accuracy in the identification and characterization of central nervous system lesions. MR findings show a good correlation with areas of parenchymal and meningeal lymphohistiocytic infiltration5, demonstrating diffuse white matter abnormalities in the early stages and necrotic areas with parenchymal volume loss as terminal findings4. In addition, MR allows the follow-up after chemotherapy and bone marrow transplantation2,3. Although rare, EL should be differentiated from other pediatric patchy white matter abnormalities5.


2014 ◽  
Vol 341 (1-2) ◽  
pp. 73-78 ◽  
Author(s):  
Jeffrey R. Wozniak ◽  
Bryon A. Mueller ◽  
Kelvin O. Lim ◽  
Laura S. Hemmy ◽  
John W. Day

2013 ◽  
Vol 115 ◽  
pp. S49-S54 ◽  
Author(s):  
Tereza Gabelic ◽  
Bianca Weinstock-Guttman ◽  
Rebecca Melia ◽  
Norah Lincoff ◽  
Muhammad W. Masud ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document